The Discounted Cash Flow (DCF) valuation of AnaptysBio Inc (ANAB) is (421.01) USD. With the latest stock price at 26.09 USD, the upside of AnaptysBio Inc based on DCF is -1713.7%.
Based on the latest price of 26.09 USD and our DCF valuation, AnaptysBio Inc (ANAB) is a sell. selling AnaptysBio stocks now will result in a potential gain of 1713.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 8.5% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (771.99) - (293.29) | (421.01) |
| Upside | -3059.0% - -1224.2% | -1713.7% |